- Adults
- People at high risk of STIs
- People living with HIV
- PrEP users
- Hospital wide
- Outpatient clinic
- Monkeypox virus
- Monkeypox virus infection
- Blood sample
- Pharmacological intervention
- Vaccination
- JYNNEOS
Central Data Repository
Explore the Central Data Repository: Use the filters and keyword search box on the left to find relevant studies. As you refine your search, the map and study list will automatically update to reflect your selections. Selecting a study from the list will provide detailed information about the specific study in question. A full legend can be found here
{content}
Study list
- Adults
- General population
- Elderly
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- BC 007
- Adults
- General population
- Elderly
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Probiotic
- Adults
- General population
- Elderly
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Rehabilitation
- Adults
- General population
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Rehabilitation
- Adults
- General population
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Antivirals
- Nirmatrelvir/Ritonavir
- Adults
- General population
- Elderly
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Immunoadsorption
- Adults
- General population
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Rehabilitation
- Fimo Health App
- Adults
- General population
- Elderly
- Fragile population
- Hospital wide
- Emergency department
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Remdesivir
- Monoclonal antibodies
- Nirmatrelvir/Ritonavir
- Sotrovimab
- Adults
- Elderly
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Rehabilitation
- Adults
- Elderly
- Fragile population
- Immunocompromised host
- Hospital wide
- Infectious diseases unit
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Remdesivir
- Monoclonal antibodies
- Nirmatrelvir/Ritonavir
- Sotrovimab
- Adults
- General population
- Elderly
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Rehabilitation
- Neurostimulation